Pay in 4 interest-free payments of $30.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
80(13):1138-42
arresting the initiation of this cascade
Smiles: C[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)C1=CC=NO1)C1CCCCC1)C(=O)N[C@@H](CCCNC(N)=N)C(N)=O
invasion and proliferation of pancreatic cancer cells
decreased cell proliferation
Cabotegravir 19218 80(13):1138-42Cabotegravir is a potent HIV integrase inhibitor as an oral lead in tablet and long acting injectable for the treatment and prevention of HIV infection. Cabotegravir is an inhibitor of OAT1 (IC50 0. 81 M) and OAT3 (IC50 0. 41 M). IC50 value: 0. 81 M (OAT1), 0. 41 M (OAT3) Target: OAT1, OAT3Cabotegravir is a potent HIV integrase inhibitor in clinical development as an oral lead in tablet and long acting injectable for the treatment and prevention of
US$ 163.00
US$ 28.00
US$ 116.00
US$ 70.00
US$ 10.00
US$ 29.00
US$ 12.00
US$ 150.00
US$ 35.00
US$ 18.00